Curis (CRIS) EBITDA Margin (2010 - 2025)
Curis' EBITDA Margin was 1729.88% in Q4 2025, up 1998.28 percentage points from -268.40% a year earlier and up 1946.88 percentage points from the prior quarter.
Powered by 
Analysis
Curis (CRIS) EBITDA Margin (2010 - 2025) Analysis & Trends
For FY2025, EBITDA Margin at Curis came in at -58.38%, up 348.10 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +170.08 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -406.48% in FY2024 (+72.74 pp), -479.22% in FY2023 (+40.24 pp), -519.45% in FY2022 (-126.32 pp) and -393.14% in FY2021 (-164.67 pp).
- The Q4 2025 figure marks the highest quarterly EBITDA Margin in data going back to Q3 2010.
- Compared with a year earlier, EBITDA Margin has increased for seven straight quarters, with an average year-over-year change of +340.72 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2025 (a gain of 1998.28 percentage points); the worst was Q1 2022 (a drop of 333.89 percentage points).
- Per Business Quant data, CRIS's EBITDA Margin in the three quarters before Q4 2025 was -217.00% (Q3 2025), -298.62% (Q2 2025) and -424.29% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Curis | 1.62 Mn | -32.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,729.88% |
| Sep 30, 2025 | -217.00% |
| Jun 30, 2025 | -298.62% |
| Mar 31, 2025 | -424.29% |
| Dec 31, 2024 | -268.40% |
| Sep 30, 2024 | -358.44% |
| Jun 30, 2024 | -489.00% |
| Mar 31, 2024 | -594.68% |
| Dec 31, 2023 | -448.44% |
| Sep 30, 2023 | -434.35% |
| Jun 30, 2023 | -549.57% |
| Mar 31, 2023 | -503.40% |
| Dec 31, 2022 | -350.81% |
| Sep 30, 2022 | -444.07% |
| Jun 30, 2022 | -627.54% |
| Mar 31, 2022 | -733.93% |
| Dec 31, 2021 | -398.31% |
| Sep 30, 2021 | -329.45% |
| Jun 30, 2021 | -464.09% |
| Mar 31, 2021 | -400.05% |
API Access
Curis EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRIS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CRIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();